Effects of collagen type on the behavior of adult canine annulus fibrosus cells in collagen-glycosaminoglycan scaffolds.

The healing of intervertebral disc defects may be improved by the implantation of cell-seeded collagen-based scaffolds. The present study evaluated in vitro the effects of the collagen type (type I vs type II) from which the scaffolds were fabricated on the behavior of adult canine annulus fibrosus cell-seeded collagen-glycosaminoglycan (GAG) scaffolds. Protein and GAG biosynthesis continued through the 8-week period of the experiment, demonstrating the viability of the cells in type I and type II collagen-GAG scaffolds. Statistical analysis revealed no significant effect of the type of collagen that makes up the scaffold on the biosynthetic activity. For both scaffold types, the amount of retained newly synthesized proteins increased from 1 to 2 weeks and from 6 to the 8 weeks. In contrast, the rate of GAG retention increased to a maximum at 4 weeks for both types of scaffolds, then decreased to about 50% of that level after 8 weeks. The number of cells generally increased the first week but then decreased in type I scaffolds while remaining constant in type II scaffolds. It could be assumed that most newly synthesized protein was lost to the medium, as the quantity of protein and collagen remained constant. Cell-mediated contraction of the scaffolds contributed to folds that formed in the constructs and to create an oriented architecture tissue. These findings commend the use of a type II collagen-GAG scaffold for further study on the basis of its maintenance of cell number and the slightly higher accumulated GAG content.

[1]  A. Grodzinsky,et al.  Effects of a cultured autologous chondrocyte‐seeded type II collagen scaffold on the healing of a chondral defect in a canine model , 2003, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[2]  M. Bayliss,et al.  The Large Proteoglycans of the Human Intervertebral Disc: Changes in Their Biosynthesis and Structure with Age, Topography, and Pathology , 1995, Spine.

[3]  S. Scully,et al.  Effect of type II collagen in chondrocyte response to TGF-beta 1 regulation. , 1998, Experimental cell research.

[4]  H. Gruber,et al.  Characterization and phenotypic stability of human disc cells in vitro. , 1997, Matrix Biology.

[5]  A. Grodzinsky,et al.  Fluorometric assay of DNA in cartilage explants using Hoechst 33258. , 1988, Analytical biochemistry.

[6]  T. Oegema,et al.  Initial characterization of the metabolism of intervertebral disc cells encapsulated in microspheres , 1992, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[7]  M. Spector,et al.  Near‐terminus axonal structure and function following rat sciatic nerve regeneration through a collagen‐GAG matrix in a ten‐millimeter gap , 2000, Journal of neuroscience research.

[8]  S. Scully,et al.  Extracellular collagen modulates the regulation of chondrocytes by transforming growth factor‐β1 , 1997, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[9]  M. Spector,et al.  Expression of α‐smooth muscle actin in canine intervertebal disc cells in situ and in collagen‐glycosaminoglycan matrices in vitro , 1999, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[10]  E. Thonar,et al.  Metabolism of the Extracellular Matrix Formed by Intervertebral Disc Cells Cultured in Alginate , 1997, Spine.

[11]  H E Gruber,et al.  Human intervertebral disc cells from the annulus: three-dimensional culture in agarose or alginate and responsiveness to TGF-beta1. , 1997, Experimental cell research.

[12]  Edward Y Lee,et al.  Synthesis and characterization of a model extracellular matrix that induces partial regeneration of adult mammalian skin. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[13]  D. Buttle,et al.  Improved quantitation and discrimination of sulphated glycosaminoglycans by use of dimethylmethylene blue. , 1986, Biochimica et biophysica acta.

[14]  M. Spector,et al.  Healing of canine articular cartilage defects treated with microfracture, a type‐II collagen matrix, or cultured autologous chondrocytes , 2000, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[15]  M. Spector,et al.  Effect of passage number and collagen type on the proliferative, biosynthetic, and contractile activity of adult canine articular chondrocytes in type I and II collagen-glycosaminoglycan matrices in vitro. , 2004, Tissue engineering.

[16]  S. Ayad,et al.  1991 Volvo Award in Basic Sciences: Collagen Types Around the Cells of the Intervertebral Disc and Cartilage End Plate: An Immunolocalization Study , 1991, Spine.

[17]  C B Sledge,et al.  Canine chondrocytes seeded in type I and type II collagen implants investigated in vitro. , 1997, Journal of biomedical materials research.

[18]  D. Eyre,et al.  Quantitative analysis of types I and II collagens in human intervertebral discs at various ages. , 1977, Biochimica et biophysica acta.

[19]  M. Spector,et al.  Proteoglycans synthesized by canine intervertebral disc cells grown in a type I collagen-glycosaminoglycan matrix. , 2002, Tissue engineering.